Today’s top gainers include the company Gilead Sciences Inc. (NASDAQ:GILD) which is in the industry Biotechnology, gaining -0.22% today. In the last week its performance is 3.40%, and -1.63% for the past quarter. Currently, Gilead Sciences Inc., GILD has a target price of 104.5, so today’s gain of -0.22% is a significant step towards its target price. The GAP today is therefore 0.33%.
Gilead Sciences Inc. (NASDAQ:GILD), has a market cap of 107633.3, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 80.50%.
At the current price of 81.52, it has a dividend yield of 2.31%, and its target price is 104.5. This is with a profit margin of 50.50%, and total debt/equity of 1.42. Gilead Sciences Inc. (NASDAQ:GILD) has a P/E of 7.18, as well as a forward P/E of 7.01.
With a current EPS of 11.35, and a forecasted EPS growth for next year at -1.17%,Gilead Sciences Inc. (NASDAQ:GILD) has had a EPS growth for the past five years at 48.30%. For the next five years EPS growth is projected to be -0.21%.
Performance for the year is -21.10%. Since its IPO date on 1/22/1992, the total performance to date is -18.10%.
Volume today for Gilead Sciences Inc. (NASDAQ:GILD), is 8184300, while its average volume is 10654.13. Whilst the total gain today was -0.22%, it did have a day high of -7.69%.
Volatility for this week has been at 1.61%, and 1.66% for the month. The 52-week low for Gilead Sciences Inc., GILD has been 6.97%, while the 52-week-high has reached -25.09%.
Looking at its return of investments, which is 45.90%, and its return on assets is 32.70%. Gilead Sciences Inc. (NASDAQ:GILD) has an operating margin of 63.00%. With a sales growth of -5.70% quarter over quarter. Bearing in mind that Gilead Sciences Inc., GILD is in the sector Healthcare, its long-term debt/equity is 1.38, and has a current ratio of 1.8 and 1.6 for quick ratio.
So what is the value of Gilead Sciences Inc.? Well its PEG is *TBA, and the P/S is 3.32, along with a P/B of 7. Meanwhile it has a p/cash of 12.3.